Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
<h4>Background</h4>Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence...
Guardado en:
Autores principales: | Geoffrey K Spurling, Peter R Mansfield, Brett D Montgomery, Joel Lexchin, Jenny Doust, Noordin Othman, Agnes I Vitry |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/409473a2419044e0a7a3ee3bbc06ea6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quality of pharmaceutical advertisements in medical journals: a systematic review.
por: Noordin Othman, et al.
Publicado: (2009) -
FINANCIAL ANALYSIS OF PHARMACEUTICAL COMPANIES
por: E. Sedova, et al.
Publicado: (2016) -
Prescribed aggression of fishes: Pharmaceuticals modify aggression in environmentally relevant concentrations
por: Pavla Hubená, et al.
Publicado: (2021) -
Factors affecting physicians\' decisions in using national and foreign brands in prescribing medicine
por: Mahsa Mahmoodi, et al.
Publicado: (2020) -
Special Low Protein Foods Prescribed in England for PKU Patients: An Analysis of Prescribing Patterns and Cost
por: Georgina Wood, et al.
Publicado: (2021)